Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ebfd716a6d868cec0fdcf2af2480107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d22b649c54d79d7c1eabf23085b14a3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a416da301af6529e8ad52a5249e6445 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-015 |
filingDate |
2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8451ceecdcc0bdee1b3cfa4c5841cfab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65805570116e0461c6f0ff149be6a350 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e01712c654de071dfd4c93bc91158458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff7540e18e34d7b81c533625bb3ab2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_193802af77cbb7a3696e8ad5c1987ff5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_231411374e2aa290d0afd6feff91d840 |
publicationDate |
2011-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1802336-B1 |
titleOfInvention |
Malaria prime/boost vaccines |
abstract |
The invention relates to novel vaccine regimens in which specific prime/boost regimens are applied using low-neutralized recombinant adenoviral vectors harboring nucleic acids encoding antigens from Plasmodium falciparum and purified recombinant protein vaccines such as RTS,S, in the context of appropriate adjuvants. |
priorityDate |
2004-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |